Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

She has no credibility with me no matter how delighted she claims to be. The long fallow period of no partnerships is a black cloud that is hovering over this company. If we had even one or two come in per year over the last three years or so, this stock would have reached $100. Yes, the current old crop of partnerships is bearing fruit, but the steam will eventually run out without new fuel in the engine. You know that, of course.